Operating Lease, Right-of-Use Asset of Inhibitor Therapeutics, Inc. from 31 Mar 2025 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inhibitor Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2025 to 30 Sep 2025.
  • Inhibitor Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $71,081.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)

Inhibitor Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $71,081 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $77,734 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $84,268 31 Mar 2025 10-Q 14 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.